The insertion/deletion (I/D) polymorphism of the angiotensin converting enzyme (ACE) gene may be involved in determining blood pressure changes. The aim of the present study was to assess the relationship between the ACE I/D gene and the change of blood pressure levels during follow-up. We calculated the difference between mean levels of SBP, DBP and PP obtained during the two observations as follows: BP mean levels obtained at third phase minus the BP mean levels at baseline and subsequently we investigated the association of the ACE I/D polymorphism and the mean changes of SBP, DBP and PP levels. The study was conducted within the Rotterdam Study, a population-based cohort study including subjects aged 55 years and older. Information on the II, ID and DD genotypes of the ACE gene and mean change of blood pressure levels were available in 3966 subjects. In adjusted models, subjects with the D allele had higher mean changes of systolic and pulse pressure (PP) than subjects with the I allele. The mean changes of systolic blood pressure were 6.1 (4.7-7.5), 8.2 (7.5-9.3) and 7.4 (5.9-8.5) mm Hg in subjects with the II, ID and DD genotype, respectively. The corresponding mean changes of PP through genotypes were 4.3 (3.3-5.4), 6.0 (5.3-6.7) and 5.9 (4.9-6.9) mm Hg, respectively. No difference was found for mean change of diastolic blood pressure among genotypes. In conclusion, the results of this population-based study show that the ACE ID/DD genotypes are associated with increased mean changes of systolic and PP.
Introduction
There is increasing evidence that pulse pressure (PP) in older age is an independent predictor of risk of cardiovascular disease in the general population. [1] [2] [3] Findings from the Framingham Heart Study 4 showed that with increasing age, there was a gradual shift in predictive value from diastolic blood pressure (DBP) to systolic blood pressure (SBP) and then to PP. From 60 years and older, PP became superior to SBP and DBP in predicting coronary heart disease.
Genetic factors might influence blood pressure levels and several studies have investigated the possible relation between the angiotensin converting enzyme (ACE) I/D gene polymorphism and blood pressure levels; however, results have been controversial. Large population-based studies have shown the effect of the ACE I/D polymorphism on blood pressure levels in men, 5, 6, 7 and a higher prevalence of hypertension has been found in smokers with the D allele. 8 Recent studies suggested that the ACE I/D gene polymorphism might modulate independently age -related increases of PP; 9, 10 however, considering the cross-sectional nature of the investigation these results require to be confirmed by longitudinal studies. The aim of the present study was to investigate whether the ACE gene I/D polymorphism could modulate blood pressure changes in a large population-based study of older adults.
Subjects and methods
This study was conducted within the framework of the Rotterdam Study, an ongoing prospective population-based cohort study among subjects aged 55 years or older, living in Ommoord, a suburb of Rotterdam, The Netherlands. The rationale and design of the Rotterdam Study have been described elsewhere. 11 The Medical Ethics Committee of Erasmus Medical Center approved the study and written consent was obtained from all participants. Baseline data were collected from 1990 to 1993 and the third examination phase took place from 1997 to 1999. In total, 7983 (response rate 78%) subjects agreed to participate and were interviewed at home.
Blood pressure measurements and cardiovascular risk factors Information on cardiovascular risk factors was collected during the baseline and the follow-up examination. Data on use of blood pressure-lowering medication and smoking habits were obtained during the home interview. Blood pressure was measured twice, at the right upper arm using a random zero sphygmomanometer, with the individual in the sitting position after a minimum of 5 m rest. Participants were asked to abstain from smoking and drinking alcoholic or caffeine, containing beverages at least 2 h before blood pressure measurements were taken. The average of two measurements, obtained at a single visit, was used for analysis. SBP, first Korotkoff phase and DBP, fifth Korotkoff phase, blood pressure were measured. PP was calculated (SBP-DBP). Body mass index (weight/height 2 ) was calculated. Serum total cholesterol and high-density lipoprotein (HDL) cholesterol values were determined by an automated enzymatic procedure (Boehringer Mannheim System). Diabetes mellitus was defined as the use of blood glucose lowering medication and/or a fasting serum glucose level equal to or greater than 7.0 mmol/l. 12 Hypertension was defined as a blood pressure level X160/ 90 mm Hg and/or the use of antihypertensive medication.
Genotype investigations
The II, ID and DD genotypes were determined at baseline, in blood samples obtained at baseline, using the polymerase chain reaction technique (PCR) using a PE9600 PCR machine according to the method of Lindpaintner et al. 13 . with some modifications. The results of amplification were 319-and 597-bp amplicons for the D and I alleles respectively. Because the D allele in heterozygous samples is preferentially amplified, there is a tendency of misclassification for about 4-5% of ID genotypes to DD. To avoid this misclassification, a second independent PCR has been performed with a primer pair that recognizes an insertion-specific sequence. The reaction yielded a 335-bp amplicon only if the I allele was present. In the post-PCR analyses, 10 ml of PCR product was loaded on 3% agarose gel. Two independent investigators have read pictures from each gel and all ambiguous samples were analysed a second time.
Population for analysis
Blood pressure measurements were available in 7009 subjects participating at baseline examination and in 4170 subjects who participated the third examination phase. In total, blood pressure measurements and information on the ACE genotype were available in 3966 subjects. Missing information on measures of blood pressures or ACE genotype was almost entirely due to logistic reasons.
Data analysis
The ACE genotype was tested as three class variables (presence of 0, 1, or 2 D alleles). The Hardy-Weinberg equilibrium was tested by a w 2 -test. The association of the ACE genotype with changes of blood pressure levels was investigated by analysis of variance after adjustment for age, gender, body mass index, diabetes mellitus, smoking, total cholesterol, HDL cholesterol and use of antihypertensive medication. We calculated the difference between mean levels of SBP, DBP and PP obtained during the two observations as follows: BP mean levels obtained at third phase minus the BP mean levels at baseline and subsequently we investigated the association of the ACE I/D polymorphism and the mean changes of SBP, DBP and PP levels. Next, the association between blood pressure changes and the ACE genotype was investigated in categories of gender, age (subjects younger and older than 70 years) and hypertension.
Results
Characteristics of the study subjects are presented in Table 1 . ACE genotype and allele proportion were in Hardy-Weinberg equilibrium. At baseline, no difference was seen between mean levels of PP or the prevalence of hypertension and the I/D polymorphism of the ACE gene. Subjects with the ID and DD genotype had a statistically significantly higher increase of mean levels of SBP and PP when compared with subjects with the genotype II ( Table 2 ). In analyses adjusted for potential confounders, mean changes and corresponding 95% confidence intervals of SBP were 6.1 (4.7-7.5), 8.2 (7.5-9.3) and 7.4 (5.9-8.5) mm Hg in subjects with the II, ID and DD genotype, respectively. The corresponding changes of DBP levels were 1.5 (0.6-2.1), 2.0 (1.6-2.5) and 1.2 (0.5-1.9) mm Hg. Finally, the corresponding mean changes of PP through genotypes were 4.3 (3.3-5.4), 6.0 (5.3-6.7) and 5.9 (4.9-6.9) mm Hg, respectively. Results of analyses performed in strata of age are presented in Table 3 .
Discussion
In this large population-based study, we have found that subjects with the ID and DD genotype of the ACE I/D gene polymorphism had a higher increase of both pulse and SBP during follow-up when compared with subjects with the II genotype. We found no difference of DBP changes among genotypes.
Blood pressure levels changes with age and it has been shown that PP, which is a consequence of large artery stiffness, increases linearly with age and is the dominant haemodynamic factor in older adults. 14 Long-term followup studies in large populations have emphasized that the levels of pulse and SBP, in addition to their rates of change with age, contribute substantially to cardiovascular risk. 3, 4, 15 Therefore it is interesting to know which variables can influence the development of wide PP. Previous studies found the D allele of the ACE gene to be associated with mean increases of PP in subjects with hypertension. 9, 10 However, these studies were crosssectional and included relatively small number of participants. To the best of our knowledge, no large population-based ongoing study has investigated the association of the ACE I/D gene polymorphism and PP changes over time. In a previous study, 16 we found that the D allele of the ACE gene was associated with increased arterial stiffness, which is responsible for wide PP. This is the first large prospective population-based study investigating whether the ACE I/D gene polymorphism is associated with changes of the PP during follow-up; in this study, we found that subjects with the D allele of the ACE gene polymorphism present a higher increase of pulse and SBP when compared with subjects with the I allele over time. The mean increase of the systolic and pulse blood pressure levels is higher in older subjects.
The mechanisms that may modulate the relation between ACE gene and wide PP levels are not completely clear. Higher circulating levels and tissue ACE activity are present in subjects with the D compared to the I allele [17] [18] [19] ACE catalyses the conversion of angiotensin I to II and the breakdown of bradykinin to kinin degradation products. Both angiotensin II and bradykinin are potent peptide hormones that play a role in vascular wall homeostasis reducing vascular tone, vascular smooth muscle cell growth and production of extracellular matrix. [20] [21] [22] [23] These processes may then lead to progressive degeneration of arterial media with fractures and fragmentation of elastic lamellae, increased collagen and calcium content and dilation and hypertrophy of the large arteries with subsequent increased arterial stiffness. Hence, chronic exposure to high levels of circulating and tissue ACE may predispose to increased arterial stiffness and eventually to higher PP.
We found the highest mean increases of the systolic and pulse blood pressure in subjects with the ID polymorphism the differences in systolic and pulse blood pressure between subjects with the ID and the DD polymorphism were minimal and were not statistically significant. One possible explanation for these results could be a higher morbidity and mortality rate in subjects with the DD polymorphism and stiff arteries; in this case, these subjects were not able to be included in the study. Conversely, in stratified analyses, we found that older subjects (470 years) and hypertensive subjects with the DD polymorphism had the highest mean increase of the PP.
Some aspects of this study need to be discussed. Information on blood pressure levels was not available for all participants, which was primarily due to logistic reasons, therefore, we believed that this will not have biased the results. Second, information on blood pressure levels were obtained on a single occasion and the use of multiple blood pressure measurements or the use of ambulatory monitoring would improve accuracy and precision.
Third, we did not exclude subjects who used antihypertensive medication and this could bias our results. However, we performed multivariate analyses adjusted also for the use of antihypertensive medication we think that in this way we could avoid bias. Finally, since the population of the Rotterdam Study consisted mostly of Caucasians, results may not apply to other ethnic groups.
In conclusion, in a large population-based study, we found that subjects with the ID and DD genotype of the ACE I/D gene polymorphism had a higher increase of both pulse and SBP during followup when compared with subjects with the II genotype. However, determining the relative contribution of genetic and environmental factors in the development of complex diseases is difficult. As regulation of blood pressure levels most probably results from a complex of interactions between gene-gene and gene-environment factors, the findings of the present study on candidate genes for blood pressure levels should be carefully interpreted.
